Genomics

Dataset Information

Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade


ABSTRACT: Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade

PROVIDER: PRJNA1177414 | ENA |

REPOSITORIES: ENA